$Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.$

Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.

OBJECTIVE: To evaluate the efficacy and safety of tumor necrosis factor (TNF) inhibition with the p55 TNF receptor fusion protein (TNFr-Ig) for severe sight-threatening noninfectious posterior segment intraocular inflammation. METHODS: Seventeen patients with refractory noninfectious posterior segm...

Bibliografiset tiedot
Päätekijät:	Murphy, C, Greiner, K, Plskova, J, Duncan, L, Frost, A, Isaacs, J, Rebello, P, Waldmann, H, Hale, G, Forrester, J, Dick, A
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2004

Samankaltaisia teoksia

Intravitreal steroid implants in the management of noninfectious intermediate and posterior uveitis
Tekijä: Sarjak M Shah, et al.
Julkaistu: (2025-01-01)

Intraocular therapy in noninfectious uveitis
Tekijä: Rocco Luigi Modugno, et al.
Julkaistu: (2021-10-01)

Emerging Therapies for Noninfectious Uveitis: What May Be Coming to the Clinics
Tekijä: Jose R. Maya, et al.
Julkaistu: (2014-01-01)

Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis
Tekijä: Swetha Palla, et al.
Julkaistu: (2015-01-01)

Campath-1H therapy in refractory ocular inflammatory disease.
Tekijä: Dick, A, et al.
Julkaistu: (2000)

Case Report: A Promising Treatment Strategy for Noninfectious Uveitis
Tekijä: Xiao-Bao Liu, et al.
Julkaistu: (2022-01-01)

Experiences of burden and needs in caregivers with pediatric noninfectious uveitis: a qualitative study
Tekijä: Jiali Huang, et al.
Julkaistu: (2024-12-01)

OCT Angiography in Noninfectious Uveitis: A Description of Five Cases and Clinical Applications
Tekijä: Samyuktha Melachuri, et al.
Julkaistu: (2023-03-01)

Immunosuppressive Medications and COVID-19 Outcomes in Patients with Noninfectious Uveitis in the Era of COVID-19 Vaccinations
Tekijä: Samantha J. Sechrist, BS, et al.
Julkaistu: (2024-03-01)

Risk of Recurrent Noninfectious Uveitis After Coronavirus Disease 2019 Vaccination in the United States
Tekijä: Anika Kumar, BA, et al.
Julkaistu: (2024-07-01)

Practice patterns regarding regional corticosteroid treatment in noninfectious Uveitis: a survey study
Tekijä: Matthew McHarg, et al.
Julkaistu: (2022-01-01)

Topical Corticosteroid-Resolved Rubeosis Iridis with Neovascular Glaucoma Caused by Noninfectious Granulomatous Uveitis
Tekijä: Daisuke Sora, et al.
Julkaistu: (2018-03-01)

A Network of Serum Proteins Predict the Need for Systemic Immunomodulatory Therapy at Diagnosis in Noninfectious Uveitis
Tekijä: Jonas J.W. Kuiper, PhD, et al.
Julkaistu: (2022-09-01)

Cost-Effectiveness Analysis of Fluocinolone Acetonide Intravitreal (FAI) Implant for Chronic Noninfectious Uveitis Affecting the Posterior Segment of the Eye (NIU-PS) in China
Tekijä: Xin Mao, et al.
Julkaistu: (2024-04-01)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
Tekijä: Lockwood, C, et al.
Julkaistu: (1993)

Comprehensive Treatment of Noninfectious Uveitis Accompanied by Macular Edema with the Use of Autologous Platelet-Rich Plasma
Tekijä: N. S. Arbenyeva, et al.
Julkaistu: (2019-08-01)

Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis.
Tekijä: Dick, A, et al.
Julkaistu: (1998)

Inhibiting tumour necrosis factor (TNF) modulates chorioretinal infiltrating T cell phenotype in experimental autoimmune uveoretinitis (EAU).
Tekijä: Dick, A, et al.
Julkaistu: (1997)

Case report: Effectiveness of Janus kinase inhibitors in the management of isolated noninfectious uveitis: a case series
Tekijä: Nina Vidic Krhlikar, et al.
Julkaistu: (2025-03-01)

Quantitative levels of interferon gamma as a biomarker in the aqueous and serum samples of infectious and noninfectious uveitis patients
Tekijä: Sahar Saad Eldeen Mohamed Shaban, et al.
Julkaistu: (2025-02-01)

A Review of Ocular Drug Delivery Platforms and Drugs for Infectious and Noninfectious Uveitis: The Past, Present, and Future
Tekijä: Christopher D. Conrady, et al.
Julkaistu: (2021-08-01)

Tofacitinib for refractory uveitis and scleritis
Tekijä: Michael A. Paley, et al.
Julkaistu: (2019-03-01)

Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet’s Disease, Sarcoidosis, and Noninfectious Uveitis
Tekijä: Daniel Sánchez-Cano, et al.
Julkaistu: (2013-01-01)

Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review
Tekijä: Lianna Valdes, et al.
Julkaistu: (2022-09-01)

Efficacy of adalimumab in noninfectious pediatric uveitis: Analysis of 29 eyes from a tertiary eye care center in India
Tekijä: Nida Khan, et al.
Julkaistu: (2024-12-01)

Comparative Efficacy and Safety of Advanced Intravitreal Therapeutic Agents for Noninfectious Uveitis: A Systematic Review and Network Meta-Analysis
Tekijä: Weiting Liao, et al.
Julkaistu: (2022-04-01)

Management of noninfectious scleritis
Tekijä: Ahmad Abdel-Aty, et al.
Julkaistu: (2022-01-01)

Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment
Tekijä: Dhingra Narendra, et al.
Julkaistu: (2010-01-01)

Posterior uveitis of toxoplasmic infection
Tekijä: Roy I, et al.
Julkaistu: (1979-01-01)

Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA
Tekijä: Engelhard SB, et al.
Julkaistu: (2015-08-01)

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study
Tekijä: Alice Bitossi, et al.
Julkaistu: (2019-01-01)

Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatment
Tekijä: Jo L. Dehoorne, et al.
Julkaistu: (2023-12-01)

Frequency and Treatment Regimens of Macular Edema in 1946 Consecutive Patients with Noninfectious Uveitis at a Tertiary Ophthalmic Center in Shaanxi, China
Tekijä: Yan-Qi Xue, et al.
Julkaistu: (2023-07-01)

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies.
Tekijä: Lockwood, C, et al.
Julkaistu: (1996)

Educational Case: Noninfectious Esophagitis
Tekijä: Tara Narasimhalu BA, et al.
Julkaistu: (2019-12-01)

Very Severe and Refractory Noninfectious Cystitis in Patients with Systemic Lupus Erythematosus: Potential Role of Rituximab Therapy
Tekijä: Vanessa Ocampo-Piraquive, et al.
Julkaistu: (2021-01-01)

Bilateral Posterior Uveitis Due to Syphilis
Tekijä: Ali Ilgın OLUT, et al.
Julkaistu: (2018-12-01)

Indocyanine green angiography in posterior uveitis
Tekijä: Rupesh V Agrawal, et al.
Julkaistu: (2013-01-01)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
Tekijä: Isaacs, J, et al.
Julkaistu: (1995)

Systemic Treatments for Noninfectious Vitreous Inflammation
Tekijä: Angela Jiang, et al.
Julkaistu: (2013-01-01)